AAMI
Acadian Asset Management
AAMI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over AAMI overall, supported by stronger valuation and stronger fundamentals.
AAMI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
AAMI's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAMI.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
AAMI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.2x | $10.93 | -89% |
| Fair | 10x | $35.36 | -63% |
| Forward | 16x | $95.12 | — |
| Expensive | 19x | $64.47 | -32% |
| Current | 28x | $95.12 | — |
Historical ranges are pointers, not guarantees.
AAMI's PE is in its expensive range at 28x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over AAMI in the historical PE scenario, which offers more potential upside but is not a forecast.
AAMI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for AAMI, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
AAMI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.90 | +73% |
| Q3 2026 | $3.41 | +45% |
| Q2 2026 | $2.83 | +19% |
| Q1 2026 | $2.35 | -1.7% |
| Q4 2025 | $2.21 | -0.5% |
| Q3 2025 | $2.35 | +42% |
| Q2 2025 | $2.38 | +43% |
| Q1 2025 | $2.39 | +46% |
| Q4 2024 | $2.22 | +43% |
AAMI's earnings per share have fallen from their peak: $3.41 over the past year, against $11.93 in late 2021.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
AAMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $191.2M | +33% |
| Q2 2026 | $185.1M | +45% |
| Q1 2026 | $167M | +39% |
| Q4 2025 | $172.2M | +2.6% |
| Q3 2025 | $144.2M | +17% |
| Q2 2025 | $127.4M | +17% |
| Q1 2025 | $119.9M | +13% |
| Q4 2024 | $167.8M | +28% |
AAMI has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +8 points |
| Q2 2026 | 18% | +4.8 points |
| Q1 2026 | 25% | -1.5 points |
| Q4 2025 | 33% | -5.4 points |
| Q3 2025 | 18% | -3.5 points |
| Q2 2025 | 13% | -6.2 points |
| Q1 2025 | 27% | +4.9 points |
| Q4 2024 | 39% | +12 points |
AAMI's operating margin was 26% last quarter, up 8 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over AAMI on profitability, with a higher operating margin.
AAMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.3M | +$81.2M |
| Q2 2026 | $26M | -58% |
| Q1 2026 | -$44.9M | +$3.9M |
| Q4 2025 | $8.7M | +$27.8M |
| Q3 2025 | -$23.9M | -134% |
| Q2 2025 | $61.6M | +35% |
| Q1 2025 | -$48.8M | -$8.4M |
| Q4 2024 | -$19.1M | -145% |
AAMI has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
AAMI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -124K shares |
| 1 year | -0.7% | -247K shares |
| 3 years | -16% | -7M shares |
| 5 years | -57% | -47.6M shares |
| Available history | -59% | -50.3M shares |
AAMI has 36M diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | $103.2M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over AAMI on shareholder dilution, with a more favorable share count trend.
AAMI Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
AAMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.2 | Neutral |
| Stochastic | 51.9 | Neutral |
AAMI's weekly RSI is 68 (neutral) and its Stochastic is 52 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
AAMI PE vs Financial Services Sector
| Metric | AAMI | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 114% above |
| PE % | 92 | 63 | 29 pts above |
AAMI is trading at 28x earnings, a 114% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over AAMI on valuation relative to its sector.
AAMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $92.7 | 2.7% above |
| 20 week MA | $89.6 | 6.2% above |
| 50 week MA | $71.2 | 34% above |
| 100 week MA | $53.1 | 79% above |
| 200 week MA | $37.8 | 152% above |
AAMI has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
AAMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $19.0 | +88% |
| 2021 | $19.0 | $25.7 | +35% |
| 2022 | $25.7 | $19.3 | -25% |
| 2023 | $19.3 | $19.2 | -0.8% |
| 2024 | $19.2 | $26.9 | +40% |
| 2025 | $26.9 | $48.4 | +80% |
| 2026 YTD | $48.4 | $95.1 | +97% |
AAMI has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.